Raras
Buscar doenças, sintomas, genes...
Tumor maligno da bainha dos nervos periféricos
ORPHA:3148CID-10 · C47.9CID-11 · 2A02.10DOENÇA RARA

Um tumor maligno da bainha do nervo periférico (MPNST) é um tipo raro e muitas vezes agressivo de câncer dos tecidos moles, que pode surgir em diversas partes do corpo.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Um tumor maligno da bainha do nervo periférico (MPNST) é um tipo raro e muitas vezes agressivo de câncer dos tecidos moles, que pode surgir em diversas partes do corpo.

Pesquisas ativas
23 ensaios
110 total registrados no ClinicalTrials.gov
Publicações científicas
1.917 artigos
Último publicado: 2026 Mar 27

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Adolescent
+ adult, childhood, elderly, infancy
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: C47.9
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Características mais comuns

Início na idade adulta
1sintomas
Sem dados (1)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 1 características clínicas mais associadas, ordenadas por frequência.

Início na idade adultaAdult onset

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.917PubMed
Últimos 10 anos200publicações
Pico2025109 papers
Linha do tempo
2026Hoje · 2026🧪 1995Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

2 genes identificados com associação a esta condição. Padrão de herança: Not applicable.

SH3PXD2ASH3 and PX domain-containing protein 2ACandidate gene tested inAltamente restrito
FUNÇÃO

Adapter protein involved in invadopodia and podosome formation, extracellular matrix degradation and invasiveness of some cancer cells (PubMed:27789576). Binds matrix metalloproteinases (ADAMs), NADPH oxidases (NOXs) and phosphoinositides. Acts as an organizer protein that allows NOX1- or NOX3-dependent reactive oxygen species (ROS) generation and ROS localization. In association with ADAM12, mediates the neurotoxic effect of amyloid-beta peptide

LOCALIZAÇÃO

CytoplasmCell projection, podosome

VIAS BIOLÓGICAS (2)
Invadopodia formationCDC42 GTPase cycle
EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Ectocervix
133.9 TPM
Nervo tibial
122.7 TPM
Cervix Endocervix
116.5 TPM
Útero
90.9 TPM
Fibroblastos
75.5 TPM
OUTRAS DOENÇAS (2)
malignant triton tumormalignant perineurioma
HGNC:23664UniProt:Q5TCZ1
HTRA1Serine protease HTRA1Candidate gene tested inTolerante
FUNÇÃO

Serine protease with a variety of targets, including extracellular matrix proteins such as fibronectin. HTRA1-generated fibronectin fragments further induce synovial cells to up-regulate MMP1 and MMP3 production. May also degrade proteoglycans, such as aggrecan, decorin and fibromodulin. Through cleavage of proteoglycans, may release soluble FGF-glycosaminoglycan complexes that promote the range and intensity of FGF signals in the extracellular space. Regulates the availability of insulin-like g

LOCALIZAÇÃO

Cell membraneSecretedCytoplasm, cytosol

VIAS BIOLÓGICAS (1)
Degradation of the extracellular matrix
EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
810.7 TPM
Ovário
602.0 TPM
Cervix Ectocervix
551.9 TPM
Fibroblastos
518.4 TPM
Artéria tibial
426.1 TPM
OUTRAS DOENÇAS (5)
cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2CARASIL syndromemalignant perineuriomaHTRA1-related autosomal dominant cerebral small vessel disease
HGNC:9476UniProt:Q92743

Variantes genéticas (ClinVar)

160 variantes patogênicas registradas no ClinVar.

🧬 HTRA1: NM_002775.5(HTRA1):c.1055C>A (p.Ser352Tyr) ()
🧬 HTRA1: NM_002775.5(HTRA1):c.257G>A (p.Gly86Glu) ()
🧬 HTRA1: NM_002775.5(HTRA1):c.962C>G (p.Ala321Gly) ()
🧬 HTRA1: GRCh37/hg19 10q26.11-26.3(chr10:120998462-135427143)x1 ()
🧬 HTRA1: NM_002775.5(HTRA1):c.1120+1G>A ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 3 variantes classificadas pelo ClinVar.

3
Patogênica (100.0%)
VARIANTES MAIS SIGNIFICATIVAS
TP53: NM_000546.6(TP53):c.464C>A (p.Thr155Asn) [Pathogenic/Likely pathogenic]
NRAS: NM_002524.5(NRAS):c.181C>A (p.Gln61Lys) [Conflicting classifications of pathogenicity]
BRAF: NM_004333.6(BRAF):c.1799T>A (p.Val600Glu) [Conflicting classifications of pathogenicity]
NF1: NM_001042492.3(NF1):c.410_463del (p.Ser137_Ser155delinsCys) []
SUZ12: NM_015355.4(SUZ12):c.719G>C (p.Ser240Thr) []

Vias biológicas (Reactome)

3 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 31
2Fase 28
1Fase 17
·Pré-clínico4
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Tumor maligno da bainha dos nervos periféricos

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

11 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

110 ensaios clínicos encontrados, 23 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
1.109 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 1.109

#1

Giant malignant peripheral nerve sheath tumor: Illustrative case and surgical technique.

Surgical neurology international2026

Malignant peripheral nerve sheath tumors (MPNSTs) are one of the most difficult malignant mesenchymal neoplasms to treat. They can arise from a preexisting peripheral nerve sheath or in neurofibromatosis type 1 (NF1) patients. MPNSTs in the head-and-neck region represent approximately 2-6% of all head-and-neck sarcomas and account for 12-19% of all MPNSTs. It has an incidence of 0.001% in the general population, and prognosis is typically poor; only between 20% and 50% of patients survive 5 years after diagnosis. The complete surgical resection is recommended whenever possible. The authors report the case of a 31-year-old woman with a history of plexiform neurofibroma, who presented with recurrence with disease progression to MPNST, without association with NF1 disease. The aim of tumor resection is symptomatic relief. These tumors have a high risk of severe complications and even mortality due to various causes. The benefits - including the emotional ones - can be so significant that, despite their malignant lineage, resection and regrowth control remain worthwhile for as long as possible. Four- or six-hand surgery for these tumors can reduce bleeding, operative time, and complications.

#2

Misdiagnosed tuberculous myelitis turned out to be spinal malignant peripheral nerve sheath tumor: a case report.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026 Jan 12

Malignant peripheral nerve sheath tumors (MPNSTs) are rare, aggressive soft tissue sarcomas. Spinal involvement is uncommon, representing only 2-3% of all cases, and is typically associated with poor prognosis. Early diagnosis is challenging due to non-specific clinical and imaging findings. A 34-year-old woman presented with progressive lower limb weakness and numbness. Cerebrospinal fluid analysis revealed elevated protein and decreased glucose and chloride levels. MRI showed spinal meningeal enhancement, initially suggestive of tuberculous myelitis. Despite prolonged anti-tuberculous treatment, her condition worsened. Repeat imaging revealed an intradural extramedullary mass compressing the spinal cord. Surgical biopsy confirmed MPNST based on spindle-shaped tumor cells and complete loss of H3K27me3 expression. This case illustrates the diagnostic challenges of spinal MPNSTs, which may mimic tuberculous myelitis. When clinical features and imaging are inconclusive and response to treatment is poor, early histopathological examination remains essential for accurate diagnosis and timely management.

#3

[Malignant peripheral nerve sheath tumor presenting with Pancoast syndrome in a ‍patient with neurofibromatosis type 1].

Rinsho shinkeigaku = Clinical neurology2026 Jan 22

A 36-year-old woman with a history of neurofibromatosis type 1 (NF1) presented with acute onset of left-hand weakness, numbness, and pain. Neurological examination revealed Horner's syndrome, distal weakness in the C8-T1 myotomes, and sensory disturbances in the corresponding dermatomes. The constellation of these signs was consistent with Pancoast syndrome, involving both the sympathetic trunk and the lower brachial plexus. Nerve conduction studies demonstrated reduced distal compound muscle action potentials and reduced or absent sensory nerve action potentials from multiple nerves in the C8-T1 territories, supporting involvement of the lower trunk. Chest X-ray revealed a large apical mass, and cervical MRI showed that the mass was compressing the brachial plexus at that level, accounting for her symptoms. Histopathological examination of a specimen obtained from the apical mass confirmed malignant peripheral nerve sheath tumor (MPNST). The patient underwent multimodal treatment including partial resection, embolization, radiotherapy, and chemotherapy, which controlled tumor growth and allowed her to maintain functional independence over a two-year follow-up. This case highlights the importance of early recognition of MPNST in NF1 patients presenting with new neurological symptoms. It also underscores the value of careful neurological examination and electrophysiological studies in accurately localizing the responsible lesion.

#4

Epidemiology and prognosis of malignant peripheral nerve sheath tumor (MPNST) in Japan: A population-based analysis using the national cancer registry.

Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association2026 Mar

The national epidemiology of malignant peripheral nerve sheath tumor (MPNST) remains underexplored. We analyzed Japanese domestic statistics for MPNST using the National Cancer Registry (NCR), a population-based database launched in 2016. We analyzed 837 MPNST cases diagnosed between 2016 and 2019, comparing them with 22,685 non-MPNST soft tissue sarcomas. We assessed demographics, treatment, and survival using Kaplan-Meier and Cox proportional hazards models. The age-adjusted incidence of MPNST in Japan was 0.13 per 100,000. Unlike other sarcomas, MPNST showed a balanced sex ratio and a relatively higher proportion of adolescent and young adult (AYA) patients (18.5 % vs. 10.7 %, p < 0.001). Most MPNSTs (87.4 %) originated from the skin and soft tissues. The 3-year survival rate for MPNST patients (53.0 %) was lower than that for other sarcomas (64.3 %, p < 0.001). Surgery was associated with longer survival (hazard ratio [HR]: 2.09; p < 0.001), while no clear benefit was observed for chemotherapy or radiotherapy. Radiotherapy was more frequently used in MPNST patients (21.1 % vs. 15.6 %, p < 0.001), likely reflecting a selection bias towards non-surgical cases. This is the first study to analyze the national epidemiology and prognosis of MPNST in a socio-economically homogeneous, single ethnic group. MPNST primarily affected the skin and soft tissues, with a higher incidence in the AYA group. Surgery was associated with better outcomes, whereas chemotherapy and radiotherapy implied poorer prognosis owing to selection bias for unresectable cases. The NCR provides a valuable model for research on rare diseases in homogeneous populations.

#5

Novel genomic risk stratification model for primary high-grade malignant peripheral nerve sheath tumor (MPNST).

The Journal of pathology2026 Mar 20

Risk stratification across the three main clinical subsets of malignant peripheral nerve sheath tumor (MPNST), neurofibromatosis type I (NF1-related), sporadic, and prior radiation therapy (RT), is based mainly on clinicopathologic parameters, such as size, grade, stage, and NF1 status. Moreover, no prior study investigated the additional impact of genomic alterations in the prognosis of high-grade MPNST using clinically validated DNA targeted next-generation sequencing (NGS) panels. Our goal was to integrate clinicopathologic and genomic parameters using an elastic-net penalized Cox proportional hazards machine learning model using OncoCast for risk prediction. Herein we perform comprehensive mutational and copy number profiling using Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) on 81 primary localized high-grade MPNSTs (51% NF1-related, 38% sporadic, 11% RT-associated). The most common genomic alterations included NF1 (51% germline, 59% somatic), CDKN2A/B (62%), PRC2 components (SUZ12, EED) (53%), and TP53 (25%). Variables selected by OncoCast as significantly associated with survival were used to construct a three-tier risk stratification model for progression-free survival (PFS) and disease-specific survival (DSS). For PFS, patients with chr16 deletion were classified as high-risk, those with concurrent germline and somatic NF1 alterations as low-risk, and the remainder was assigned to the intermediate-risk group. For DSS, cases with fraction genome altered (FGA) > 50% were defined as high-risk, those with PRC2 abnormalities, CDKN2A deletion, TERT promoter mutation, or chr16 deletion as intermediate-risk, and cases lacking all the aforementioned alterations as low-risk. The high-risk group showed significantly inferior survival compared to the low-risk group (both PFS and DSS p < 0.001). Subgroup analysis showed that among NF1-related MPNST, co-occurring somatic NF1 mutation or WT TP53 was associated with superior PFS. Collectively, genomic alterations detected by clinical NGS panels provide potential new biomarkers for risk stratification that can be integrated with conventional parameters to provide improved prognostication and guide therapeutic strategies. © 2026 The Pathological Society of Great Britain and Ireland.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC991 artigos no totalmostrando 199

2026

Novel genomic risk stratification model for primary high-grade malignant peripheral nerve sheath tumor (MPNST).

The Journal of pathology
2026

Driving proteomic imbalance in malignancy provokes proteomic catastrophe and confers tumor suppression.

bioRxiv : the preprint server for biology
2026

Trametinib and Fimepinostat Induce Malignant Peripheral Nerve Sheath Tumor Cell Death In Vitro.

Cancers
2026

18F-FDG PET/CT in Epithelioid Malignant Peripheral Nerve Sheath Tumor of the Vagina.

Clinical nuclear medicine
2026

Primary Intraosseous Malignant Nerve Sheath Tumor Of Humerus Presenting With Pathological Fracture: A Rare Case Report With Review Of Literature.

Journal of orthopaedic case reports
2026

Challenging Limb Salvage in a Crural Malignant Peripheral Nerve Sheath Tumor with Pre-existing Long-Stem Implants: A Case Report.

Journal of orthopaedic case reports
2026

Refractory Cancer Pain in a Pediatric Patient With Advanced Malignant Peripheral Nerve Sheath Tumor: A Total Pain-Oriented Palliative Care Approach.

Cureus
2025

Schwannoma: a spectrum from benign to malignant.

Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
2026

Heterologous Rhabdomyoblastic Differentiation in Dedifferentiated Liposarcoma Is Significantly Associated With Loss of H3K27 Trimethylation.

Pathology international
2026

Giant malignant peripheral nerve sheath tumor: Illustrative case and surgical technique.

Surgical neurology international
2026

Breathless and Beyond: Anterior Mediastinal Malignant Peripheral Nerve Sheath Tumor as a Rare Neurofibromatosis Type 1 Manifestation.

Clinical case reports
2026

Single-cell transcriptomic profiling of malignant peripheral nerve sheath tumors.

Neuro-oncology advances
2026

Clinical Outcomes Following Surgical Resection for Patients With Malignant Peripheral Nerve Sheath Tumors.

Neurosurgery
2026

Molecular epidemiology of the expression of urokinase plasminogen activator receptor-associated protein (uPARAP) in mesenchymal malignancies.

Translational oncology
2026

Case Report: Anlotinib combined with radiotherapy achieves sustained disease control in advanced malignant melanotic nerve sheath tumor.

Frontiers in oncology
2026

Indocyanine green assists with sentinel lymph node mapping in pediatric and adolescent patients: A Pediatric Surgical Oncology Research Collaborative prospective observational study.

Cancer
2026

Personalized medicine strategy for MPNSTs: using precision oncology on PDOX models to inform tumor boards.

Journal of translational medicine
2026

Mammary malignant peripheral nerve sheath tumor in a 93-year-old male: case report.

Journal of surgical case reports
2026

High-grade malignant peripheral nerve sheath tumor of the esophagus: a rare case highlighting the diagnostic value of immunohistochemistry.

Journal of surgical case reports
2026

Intraoperative pafolacianin for nodule detection during VATS metastasectomy in extremity metastatic sarcoma surgery performed concurrently.

Journal of cardiothoracic surgery
2026

Protein kinase-related tumors in the pediatric population : Updated review on an emerging group with emphasis on the more rarely involved kinases.

Pathologie (Heidelberg, Germany)
2026

Biallelic NF1 Inactivation and Widespread Loss of Heterozygosity in a Subset of Unclassified Fibromyxoid Mesenchymal Neoplasms.

Genes, chromosomes &amp; cancer
2026

Outcomes following definitive treatment of malignant peripheral nerve sheath tumor are significantly worse for patients with neurofibromatosis type 1: A Canadian Sarcoma Research and Clinical Collaboration study.

Cancer
2025

A retrospective study of post-radiation sarcoma from three institutions in Japan with a review of the literature.

Nagoya journal of medical science
2025

Clinical, Cytologic, Histopathologic, and Diagnostic Imaging of a Malignant Peripheral Nerve Sheath Tumor in the Renal Pelvis of a Border Collie Dog.

Veterinary clinical pathology
2026

Pathologic Assessment of Retroperitoneal Sarcomas: A Position Paper By the Transatlantic Australasian Retroperitoneal Sarcoma Working Group.

The American journal of surgical pathology
2026

Retroperitoneal malignant peripheral nerve sheath tumor in a patient with neurofibromatosis type 1: a case report.

BMC surgery
2026

Advances in Clinical Trials of Boron Neutron Capture Therapy.

Research (Washington, D.C.)
2026

Misdiagnosed tuberculous myelitis turned out to be spinal malignant peripheral nerve sheath tumor: a case report.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2026

Distinct coexisting pathologies of oral malignant peripheral nerve sheath tumor with melanin pigmentation and indolent small lymphocytic lymphoma.

Discover oncology
2026

SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST).

Clinical cancer research : an official journal of the American Association for Cancer Research
2026

Cervical Intranodal Schwannoma and Its Malignant Transformation: A Case Report With Literature Review.

Clinical case reports
2026

Midkine as a therapeutic node in NF1-driven neuro‑oncology: Biology, biomarkers, and translational strategies.

Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie
2026

Malignant peripheral nerve sheath tumor presenting as mitral stenosis: case report and literature review.

Journal of cardiothoracic surgery
2025

Malignant peripheral nerve sheath tumors in neurofibromatosis type 1 arise from distinct nodular lesions: A retrospective imaging analysis.

Neuro-oncology advances
2025

Rapidly progressive spinal epithelioid malignant peripheral nerve sheath tumor following subtotal resection surgery: a case report.

Discover oncology
2025

Pathological and Immunohistochemical Features of Malignant Peripheral Nerve Sheath Tumor With Heterologous Rhabdomy Oblastic Differentiation (Malignant Triton Tumor) in the Context of the Malignant Peripheral Nerve Sheath Tumor Spectrum.

International journal of surgical pathology
2025

Intradural Spinal Malignant Peripheral Nerve Sheath Tumor on 18F-FDG PET/CT.

Clinical nuclear medicine
2026

When the Rare Becomes Rarer: Metastasis of Epithelioid Malignant Peripheral Nerve Sheath Tumor (MPNST) to Lymph Node and Pleural Fluid.

Diagnostic cytopathology
2026

[Malignant peripheral nerve sheath tumor presenting with Pancoast syndrome in a ‍patient with neurofibromatosis type 1].

Rinsho shinkeigaku = Clinical neurology
2026

Malignant peripheral nerve sheath tumor mimicking post-traumatic hematoma: A case report.

Radiology case reports
2025

Combined Vacuum-assisted Closure Therapy and CACIPLIQ20 for Chronic Wound Management.

Plastic and reconstructive surgery. Global open
2025

Malignant extrarenal rhabdoid tumor: a case report.

Journal of medical case reports
2025

Diagnostic challenges of the neurofibroma-malignant peripheral nerve sheath tumor spectrum in neurofibromatosis type 1: illustrative case.

Journal of neurosurgery. Case lessons
2025

Malignant Peripheral Nerve Sheath Tumor Arising After Superficial Neurofibroma Excision: A Rare Sporadic Case in a Patient Without Neurofibromatosis Type 1.

Cureus
2025

Five cases report and literature review of malignant peripheral nerve sheath tumor.

Discover oncology
2025

Cytological Features of Spindle Cell Lesions of the Head and Neck and Review of the Literature.

Acta cytologica
2025

Rigid sacropelvic fixation for lumbosacral instability following external hemipelvectomy for malignant peripheral nerve sheath tumor using CT navigation and virtual reality imaging: a case report and literature review.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
2025

PRC2 Restricts Malignant Peripheral Nerve Sheath Tumorigenesis in a Genetically Engineered Mouse Model of MPNST.

bioRxiv : the preprint server for biology
2025

Periacetabular Resection for Bone Tumors: Is There Still a Role for Massive Allograft-prosthesis Composite Reconstructions?

Clinical orthopaedics and related research
2026

Survival outcomes and prognostic factors in temporal bone malignancies: A retrospective cohort of 20 patients.

Oncology letters
2025

[Effectiveness evaluation of three-dimensional printed customized hemi-pelvic prosthesis for pelvic reconstruction after resection of massive pelvic tumor].

Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
2026

Malignant peripheral nerve sheath tumors in schwannomatosis: systematic review and meta-analysis.

Journal of neurosurgery
2026

Malignant peripheral nerve sheath tumors in schwannomatosis: a case series.

Journal of neurosurgery
2025

Perineurial Malignant Peripheral Nerve Sheath Tumor of the Cauda Equina: Diagnostic Challenge.

Diagnostics (Basel, Switzerland)
2025

Pulmonary Metastasis of Malignant Peripheral Nerve Sheath Tumor with Extensive Calcification.

Archivos de bronconeumologia
2025

The Diagnostic Ability of Texture Analysis in MR Imaging for Neurogenic Tumors.

The journal of medical investigation : JMI
2026

Updates in Peripheral Nerve Sheath and Adipocytic Tumors.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2025

Case Report: Malignant peripheral nerve sheath tumor of the kidney with a novel granular cell morphology.

Frontiers in oncology
2025

Case Report: Malignant peripheral nerve sheath tumor of the thoracic spine with postoperative recurrence and intracranial metastasis-a review of the literature.

Frontiers in oncology
2025

SOX11 is frequently expressed in ETV6::NTRK3-rearranged infantile fibrosarcoma and congenital mesoblastic nephroma.

Virchows Archiv : an international journal of pathology
2025

Salvage of necrotic flap following malignant peripheral nerve sheath tumor excision using multimodal pharmacotherapy: a case report.

Frontiers in oncology
2025

Bilateral orbital metastasis from malignant peripheral nerve sheath tumor.

Orbit (Amsterdam, Netherlands)
2025

Physiotherapy enhances gait stability in a forelimb-amputated dog undergoing postoperative radiotherapy: a case report.

BMC veterinary research
2026

Epidemiology and prognosis of malignant peripheral nerve sheath tumor (MPNST) in Japan: A population-based analysis using the national cancer registry.

Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association
2026

Sinonasal Sarcomas Management: An International Consensus Statement.

International forum of allergy &amp; rhinology
2025

Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors.

Molecular medicine (Cambridge, Mass.)
2025

Cellular schwannoma of the base of tongue: A case report.

Journal of cancer research and therapeutics
2025

Circumferentially Exposed Achilles Tendon Wound Reconstruction Using Free Anterolateral Thigh Flap With Vascularized Fascia Lata Wrapping.

Plastic and reconstructive surgery. Global open
2025

The Intersection of a Rare Mass and Dual Primary Malignancies: A 73-Year-Old Male Patient's Cardiac Conundrum.

JACC. Case reports
2025

Radiotherapy Offered Limited Additional Benefits on Cancer-specific Survival for Patients with Resectable Subcutaneous Malignant Peripheral Nerve Sheath Tumors: A Population-based Retrospective Cohort Analysis.

Neurologia medico-chirurgica
2025

Malignant peripheral nerve sheath tumor of the right forearm: Case report.

International journal of surgery case reports
2025

TRAP1 expression elicits pro-tumoral functions in macrophages associated to malignant peripheral nerve sheath tumor cells.

Journal of experimental &amp; clinical cancer research : CR
2025

Malignant peripheral nerve sheath tumor of the sigmoid colon: A case report and comparison with published cases.

International journal of surgery case reports
2025

Malignant peripheral nerve sheath tumor in the vagus nerve causing upper gastrointestinal signs in a dog.

The Journal of veterinary medical science
2025

Surgical Management of a Giant Mediastinal Schwannoma Associated with Neurofibromatosis Type 1: A Case Report.

Surgical case reports
2025

Recurrent metastatic malignant peripheral nerve sheath tumor associated with neurofibromatosis I: a rare case with atypical immunohistochemistry.

Anais brasileiros de dermatologia
2025

Translocator protein deficiency blocks the ferroptosis of malignant peripheral nerve sheath tumors through glutathione peroxidase 4.

Frontiers in cellular neuroscience
2025

Inferior vena cava division with venous-venous bypass during en bloc lumbar spondylectomy for malignant peripheral nerve sheath tumor: illustrative case.

Journal of neurosurgery. Case lessons
2025

Regional lymph node invasion in pediatric non-rhabdomyosarcoma soft tissue sarcoma: an international cohort study from the International Soft Tissue Sarcoma Consortium.

EClinicalMedicine
2025

Diagnostic Utility of PRAME in Rare Melanoma Mimics: A Comparative Analysis Including GNET, MMNST, Epithelioid MPNST, and MITF-Rearranged Melanocytic Tumors.

Journal of cutaneous pathology
2025

A Case of Myxoid Malignant Peripheral Nerve Sheath Tumor in a Patient With Carney Complex.

Case reports in pathology
2025

A Pediatric Case of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumor of the Scalp.

Plastic and reconstructive surgery. Global open
2025

Malignant Peripheral Nerve Sheath Tumor of the Rectum Characterized by Focal S100 Protein Expression.

Cureus
2025

Malignant Transformation of Tentorial Schwannoma.

Neurology India
2025

Malignant peripheral nerve sheath tumor of the parotid gland.

Medicina clinica
2025

Development of Malignant Peripheral Nerve Sheath Tumor After Keloid Treatment.

Plastic and reconstructive surgery. Global open
2026

Malignant Transformation of Schwannoma to S-100 Negative Epithelioid Malignant Peripheral Nerve Sheath Tumor: A Case Report.

International journal of surgical pathology
2025

Malignant peripheral nerve sheath tumor in early childhood: a case report of a diagnostic challenge.

Frontiers in oncology
2025

Case Report: Malignant transformation of ganglioneuroma in the rectovaginal septum to malignant peripheral nerve sheath tumor based on neurofibromas.

Frontiers in oncology
2025

Prognostic factors and treatment outcomes of malignant peripheral nerve sheath tumors (MPNST) of the extremities: A tertiary cancer institutional analysis.

Journal of orthopaedics
2025

Malignant peripheral nerve sheath tumor of the shoulder: A rare case highlighting the role of multimodal management.

Radiology case reports
2025

Single-cell tumor microenvironment profiling informs a circulating proteome test for the interception of malignant transformation in NF1 nerve sheath tumors.

Research square
2025

Ifosfamide, Carboplatin, and Etoposide as Neoadjuvant Chemotherapy in Patients With Neurofibromatosis Type I-related Malignant Peripheral Nerve Sheath Tumors.

In vivo (Athens, Greece)
2025

MTA-Cooperative PRMT5 Inhibitors Are Efficacious in MTAP-Deleted Malignant Peripheral Nerve Sheath Tumor Models.

Clinical cancer research : an official journal of the American Association for Cancer Research
2025

Malignant Triton Tumor of the Ileocolic Mesentery with Neurofibromatosis Type 1: A Case Report and Literature Review.

Surgical case reports
2025

Malignant peripheral nerve sheath tumor of the nasal cavity: a rare diagnostic and therapeutic challenge.

Journal of surgical case reports
2025

Malignant Peripheral Nerve Sheath Tumor in Children and Adolescents: Local Treatment in a Retrospective Single-Center Experience.

Pediatric blood &amp; cancer
2025

Genomic profiling and pathological assessment of malignant peripheral nerve sheath tumors.

Journal of cancer research and clinical oncology
2025

Multidisciplinary collaborative treatment of a giant malignant peripheral nerve sheath tumor on the top of the head: a case report.

Discover oncology
2025

Multimodal treatment with cisplatin for metastatic disease in malignant peripheral nerve sheath tumors: a case report and review.

Anti-cancer drugs
2025

Epithelioid Malignant Peripheral Nerve Sheath Tumor of the Breast with Breast Cancer in the Contralateral Breast: A Case Report.

Case reports in oncology
2025

Case Report: Two cases of atypical neurofibroma neoplasm of uncertain biological potential in the nasal cavity and a literature review.

Frontiers in oncology
2025

Long-Term Outcomes of Radiation Therapy for Pediatric Brain Tumors: A Single-Center Study.

Cureus
2025

Pedicled Vascularized Common Peroneal Nerve Graft in Sciatic Nerve Reconstruction With Involvement of Inner Pelvic Lumbar and Sacral Nerve Roots: A Case Report and Literature Review.

Microsurgery
2025

A pattern of local failure after preoperative 5 × 5 Gy in soft tissue sarcomas: A long-term real-world experience.

Clinical and translational radiation oncology
2025

Galectin-1 Inhibition as a Strategy for Malignant Peripheral Nerve Sheath Tumor Treatment.

Cells
2025

Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids.

SLAS discovery : advancing life sciences R &amp; D
2025

Malignant Transformation of a Vestibular Schwannoma Without Previous Radiation Exposure: Illustrative Case and Literature Review.

Journal of neurological surgery reports
2025

Malignant Peripheral Nerve Sheath Tumor (MPNST) of the Uterine Cervix - A Systematic Literature Review and New Case Report with Possible New Therapeutic Approaches.

Geburtshilfe und Frauenheilkunde
2025

Bone transport nails for reconstruction of lower limb diaphyseal defects in patients with bone sarcomas : A case series.

Wiener klinische Wochenschrift
2025

CD274/PD-L1 copy number gained malignant peripheral nerve sheath tumor: A case report and literature review.

Medicine
2025

Rapidly Growing Malignant Peripheral Nerve Sheath Tumors Arising From Neurofibromatosis Type 1: A Case Report by Rehabilitation Physicians.

Cureus
2025

Co-occurrence of breast cancer and malignant peripheral nerve sheath tumor in a patient with neurofibromatosis type 1.

International cancer conference journal
2025

CRE25-048: A Rare Tumor Presentation in a Postpartum Female: Case Report of Malignant Peripheral Nerve Sheath Tumor Accompanying Neurofibromatosis Type I Diagnosis.

Journal of the National Comprehensive Cancer Network : JNCCN
2025

Malignant Peripheral Nerve Sheath Tumors in Children and Adolescents: A Population-Based Study.

World neurosurgery
2025

The CoREST complex is a therapeutic vulnerability in malignant peripheral nerve sheath tumors.

Scientific reports
2025

Malignant peripheral nerve sheath tumor presenting in the cauda equina: diagnostic and biological pearls. Illustrative case.

Journal of neurosurgery. Case lessons
2025

DLK1 Distinguishes Subsets of NF1-Associated Malignant Peripheral Nerve Sheath Tumors with Divergent Molecular Signatures.

Clinical cancer research : an official journal of the American Association for Cancer Research
2025

Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trial.

ESMO open
2025

Cerebrospinal fluid dissemination of an intracranial malignant peripheral nerve sheath tumor in the sellar region: illustrative case.

Journal of neurosurgery. Case lessons
2025

Malignant Peripheral Nerve Sheath Tumor (MPNST) Arising from Orbital Plexiform Neurofibroma in a Small Child With Neurofibromatosis Type 1.

Cancer diagnosis &amp; prognosis
2025

Discoidin domain receptor inhibitor DDR1-IN-1 induces autophagy and necroptotic cell death in malignant peripheral nerve sheath tumor.

Cell death discovery
2025

Neuropathic Pain Following Surgery for Malignant Peripheral Nerve Sheath Tumors.

Annals of surgical oncology
2024

Primary intraosseous malignant peripheral nerve sheath tumor of clavicle: Report of a rare entity.

Indian journal of cancer
2025

Loss of H3K27me3 Is Not Specific to Malignant Triton Tumor: Immunohistochemical Analysis of 23 Cases of Embryonal Rhabdomyosarcoma.

Archives of pathology &amp; laboratory medicine
2025

Indocyanine Green as a Marker for Tissue Ischemia in Spinal Tumor Resections and Extended Revisions: A Technical Note.

Journal of clinical medicine
2025

[Artemin promotes proliferation and invasion of malignant peripheral nerve sheath tumor cells through the PI3K/Akt pathway].

Zhonghua zhong liu za zhi [Chinese journal of oncology]
2025

Primary Malignant Peripheral Nerve Sheath Tumor of the Cauda Equina: A Case Report and Literature Review.

Cureus
2025

Retroperitoneal malignant peripheral nerve sheath tumor treated with laparotomy approach: A case report.

International journal of surgery case reports
2025

The diagnostic utility of SOX11 Immunohistochemical expression in malignant peripheral nerve sheath tumors and their potential mimickers.

Annals of diagnostic pathology
2025

Difficulties in the diagnosis and treatment of axillary malignant triton tumors: A case report.

Oncology letters
2025

[Plastic surgical treatment of neurofibromatosis type 1].

Chirurgie (Heidelberg, Germany)
2024

Knee Desmoplastic Melanoma, an Uncommon Tumor, Disguised as a Malignant Peripheral Nerve Sheath Tumor: A Case Report and Review of the Literature.

Cureus
2025

Importance of the multidisciplinary approach in the surgical treatment of giant mediastinal neoplasms: a case series.

AME case reports
2025

UBR5 in Tumor Biology: Exploring Mechanisms of Immune Regulation and Possible Therapeutic Implications in MPNST.

Cancers
2025

Alternative driver pathways in peripheral nerve sheath tumors - including DICER1 and/or KRAS alterations.

The Journal of pathology
2025

Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models.

Clinical cancer research : an official journal of the American Association for Cancer Research
2024

Surgical Treatment and Targeted Therapy for a Large Metastatic Malignant Peripheral Nerve Sheath Tumor: A Case Report and Literature Review.

Life (Basel, Switzerland)
2025

Assessing the Utility of DNA Methylation Profiling in the Classification of Myogenic Sarcomas of Bone.

International journal of surgical pathology
2024

Malignant Peripheral Nerve Sheath Tumor of the Small Bowel: A Case Report and Review of the Literature.

Cureus
2024

Cellular Schwannoma of the Palate Simulating as Malignant Peripheral Nerve Sheath Tumor: A Diagnostic Marathon.

Journal of dentistry (Shiraz, Iran)
2024

Spinal intradural malignant peripheral nerve sheath tumor at the foramen magnum in a non-neurofibromatosis child.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2025

Distinguishing Characteristics of Benign Versus Malignant Intraosseous Schwannomas: A Comparative Study.

Orthopaedic surgery
2025

Trigeminal malignant peripheral nerve-sheath tumor: Systematic review, and case report treated by proton-beam therapy.

Neuro-Chirurgie
2024

Malignant Degeneration of a Peripheral Nerve Sheath Tumor in the Neck Region.

Ear, nose, &amp; throat journal
2025

Brachial plexopathy and intradural cord compression caused by malignant peripheral nerve sheath tumor a case report and literature review.

International journal of surgery case reports
2025

Plasma DNA Methylation-Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1.

Molecular carcinogenesis
2024

Perioperative Observations and Outcome in Surgical Treatment of Malignant Peripheral Nerve Sheath Tumors.

Cancers
2024

Dysregulation of miRNAs in Soft Tissue Sarcomas.

Cells
2025

Spatial Lipidomics Reveals Myelin Defects and Protumor Macrophage Infiltration in Malignant Peripheral Nerve Sheath Tumor Adjacent Nerves.

Laboratory investigation; a journal of technical methods and pathology
2024

Malignant Peripheral Nerve Sheath Tumour Presenting as Sciatica in a Patient with Neurofibromatosis Type 1: Is Magnetic Resonance Imaging an Effective Screening Tool?

European journal of case reports in internal medicine
2025

Genomic Landscape of Superficial Malignant Peripheral Nerve Sheath Tumor.

Laboratory investigation; a journal of technical methods and pathology
2025

Profiling the cancer-prone microenvironment in a zebrafish model for MPNST.

Oncogene
2024

Malignant Peripheral Nerve Sheath Tumor (MPNST) With Smooth Muscle Differentiation of the Uterus-A Case Report With Emphasis on Diagnostic Pitfalls and Value of DNA Methylation Analysis.

Genes, chromosomes &amp; cancer
2025

Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1.

Neuro-oncology
2024

Malignant peripheral nerve sheath tumor of the cervix in an adolescent with neurofibromatosis type 1: A case report and review of literature.

The journal of obstetrics and gynaecology research
2024

TGF-β superfamily-induced transcriptional activation pathways establish the RAD52-dependent ALT machinery during malignant transformation of MPNSTs.

Scientific reports
2024

Malignant Triton Tumor of the Distal Femur: A Case Report and Review of the Literature.

In vivo (Athens, Greece)
2024

A Rare Case Report of Malignant Peripheral Nerve Sheath Tumor in the Infratemporal Fossa.

Ear, nose, &amp; throat journal
2024

[Expression and its clinical significance of cell-cycle dependent kinase 1 in malignant peripheral nerve sheath tumors].

Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
2024

[Analysis of clinical features, treatment methods, and prognostic influence factors in patients with malignant peripheral nerve sheath tumor].

Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
2024

[Clinical features and surgical treatments of neurofibromas associated with neurofibromatosis type 1].

Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
2024

[Progress in neurosurgical treatment of neurofibromatosis type 1].

Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
2024

Current state of spinal nerve sheath tumor management and future advances.

Neuro-oncology advances
2025

Cauda equina malignant peripheral nerve sheath tumor presenting with subarachnoid hemorrhage: a case report.

Neurocirugia
2024

Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.

International journal of molecular sciences
2024

Inflammatory Pseudotumor of the Ulnar Nerve Mimicking a Malignant Peripheral Nerve Sheath Tumor: A Radiologic Puzzle.

Seminars in musculoskeletal radiology
2024

Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma.

Clinical cancer research : an official journal of the American Association for Cancer Research
2024

A Rare Case of Malignant Triton Tumor Without Associated Neurofibromatosis.

Cureus
2025

Radiation-Induced Intraosseous Malignant Peripheral Nerve Sheath Tumor: A Case Report.

International journal of surgical pathology
2024

Malignant peripheral nerve sheath tumor mimicking carotid body tumor, a rare case report and review of literature.

International journal of surgery case reports
2024

Neurofibromatosis to neoplasia transition: a rare case report of spindle cell malignant peripheral nerve sheath tumor with literature review.

Annals of medicine and surgery (2012)
2025

Primary Aortic Malignant Peripheral Nerve Sheath Tumor.

Vascular and endovascular surgery
2024

Malignant Transformation of Previously Radiated Vestibular Schwannoma: Two-Dimensional Operative Video.

World neurosurgery
2024

MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.

Clinical cancer research : an official journal of the American Association for Cancer Research
2024

A Case Report and Review of Diagnostic and Therapeutic Challenges of a Malignant Peripheral Nerve Sheath Tumor in the Foot.

Cureus
2024

NSD3::NUTM1 Fusion Sarcoma Mimicking Malignant Peripheral Nerve Sheath Tumor with Prolonged Survival.

Biomedicines
2024

Imaging findings of type I neurofibromatosis with outcome of malignant peripheral nerve sheath tumor in the right lower extremity.

Journal of clinical ultrasound : JCU
2024

Immunohistochemical Evaluation of Schlafen 11 (SLFN11) Expression in Cancer in the Search of Biomarker-Informed Treatment Targets: A Study of 127 Entities Represented by 6658 Tumors.

The American journal of surgical pathology
2024

Contemporary surgical management of pediatric non-rhabdomyosarcoma soft tissue sarcoma.

Pediatric blood &amp; cancer
2024

Orbital malignant peripheral nerve sheath tumor: A case report and review.

Oman journal of ophthalmology
2024

A rare Encounter with Pediatric Malignant Peripheral Nerve Sheath Tumor in Nasal Sinuses and Orbit.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
2024

Denosumab combined with chemotherapy followed by anlotinib in the treatment of multiple metastases of malignant peripheral nerve sheath tumor: a case report and literature review.

Frontiers in oncology
2024

Late-onset tumors in rhabdoid tumor predisposition syndrome type-1 (RTPS1) and implications for surveillance.

European journal of human genetics : EJHG
2025

Multiparametric whole-body MRI of patients with neurofibromatosis type I: spectrum of imaging findings.

Skeletal radiology
2024

Malignant Transformation of Plexiform Neurofibroma Due to Neglected Giant Soft Tissue Swelling of the Back: A Case Report.

Cureus
2024

TRPS1 expression in MPNST is correlated with PRC2 inactivation and loss of H3K27me3.

Human pathology
2024

A rare presentation of thyroid malignant peripheral nerve sheath tumor in neurofibromatosis type 1 delineated by FDG PET/CT: A case report and literature review.

Asia Oceania journal of nuclear medicine &amp; biology
2024

Rare primary intrapulmonary malignant peripheral nerve sheath tumor showing significant response to sintilimab: A case report and literature review.

Oncology letters
2025

Presumed myxosarcoma in the eyelid of a cat: Case report.

Veterinary ophthalmology
2024

Painless Growing Swelling on the Palm of a 4-year-old Boy: Malignant Peripheral Nerve Sheath Tumor.

Revista brasileira de ortopedia
2024

ISLET-1 expression in soft tissue neoplasms reveals high sensitivity but moderate specificity for desmoplastic small round cell tumors and potential utility as a diagnostic biomarker.

Pathology, research and practice
2024

A Pediatric Case of Intraocular Malignant Peripheral Nerve Sheath Tumor.

Journal of pediatric hematology/oncology
2024

[A case of pleural metastasis of malignant peripheral nerve sheath tumor].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
2024

Malignant Peripheral Nerve Sheath Tumor, a Heterogeneous, Aggressive Cancer with Diverse Biomarkers and No Targeted Standard of Care: Review of the Literature and Ongoing Investigational Agents.

Targeted oncology
2024

Forelimb lameness caused by malignant peripheral nerve sheath tumors of the median nerve in a dog: a case report.

The Journal of veterinary medical science
2024

Brachial plexus peripheral nerve sheath tumors (PNSTs): clinical and surgical management in the pediatric population.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2024

Outcomes of Head and Neck Neurogenic Tumors.

Cureus
Ver todos os 991 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Tumor maligno da bainha dos nervos periféricos.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Tumor maligno da bainha dos nervos periféricos

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Giant malignant peripheral nerve sheath tumor: Illustrative case and surgical technique.
    Surgical neurology international· 2026· PMID 41783196mais citado
  2. Misdiagnosed tuberculous myelitis turned out to be spinal malignant peripheral nerve sheath tumor: a case report.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology· 2026· PMID 41521307mais citado
  3. [Malignant peripheral nerve sheath tumor presenting with Pancoast syndrome in a &#x200d;patient with neurofibromatosis type 1].
    Rinsho shinkeigaku = Clinical neurology· 2026· PMID 41391863mais citado
  4. Epidemiology and prognosis of malignant peripheral nerve sheath tumor (MPNST) in Japan: A population-based analysis using the national cancer registry.
    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association· 2026· PMID 41073222mais citado
  5. Novel genomic risk stratification model for primary high-grade malignant peripheral nerve sheath tumor (MPNST).
    The Journal of pathology· 2026· PMID 41863012mais citado
  6. O-Arm Navigated En Bloc Resection of a Paraspinal Malignant Peripheral Nerve Sheath Tumor Involving the Thoracic Spine: A Case Report.
    Spine Surg Relat Res· 2026· PMID 41987994recente
  7. Near-Bloodless Resection of a Giant Hypervascular NF1-Associated Malignant Peripheral Nerve Sheath Tumor Using Dual-Modality Preoperative Embolization.
    Int J Dermatol· 2026· PMID 41966224recente
  8. Malignant Peripheral Nerve Sheath Tumor of the Pancreas: A Case Report and Updated Review of Related Literature.
    Acta Med Philipp· 2026· PMID 41959846recente
  9. Defining Prognostic Markers and Clinical Outcomes in Epithelioid Malignant Peripheral Nerve Sheath Tumor.
    Mod Pathol· 2026· PMID 41881192recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:3148(Orphanet)
  2. MONDO:0017827(MONDO)
  3. GARD:10872(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q654485(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Tumor maligno da bainha dos nervos periféricos
Compêndio · Raras BR

Tumor maligno da bainha dos nervos periféricos

ORPHA:3148 · MONDO:0017827
Prevalência
Unknown
Herança
Not applicable
CID-10
C47.9 · Neoplasia maligna dos nervos periféricos e sistema nervoso autônomo, não especificados
CID-11
Ensaios
23 ativos
Início
Adolescent, Adult, Childhood, Elderly, Infancy
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0751690
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades